Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
SYNCOMF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Syncom Formulations India Ltd has informed the stock exchanges that its Board of Directors will meet on 12th February 2026 at 3:00 PM at its corporate office in Indore. The main agenda is to consider and approve the standalone and consolidated unaudited financial results for the quarter and nine months ended 31st December 2025, along with taking on record the Limited Review Report by the auditors. The filing is a routine regulatory compliance under SEBI LODR Regulation 29(1)(a) ahead of the Q3 results announcement.
This is a standard pre-results intimation and contains no financial data. Investors should watch for the actual Q3FY26 results, which will be announced after the board meeting on 12th February 2026. The announcement itself is unlikely to move the stock price.